Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer

Journal:

Cancer Cell

Published:

2025-08-28

DOI:

10.1016/j.ccell.2025.07.015

Affiliations:

8

Authors:

20

Go to article

Institutions	Authors	Share
University of California, San Francisco (UCSF), United States of America (USA)	13.000000 13.000000	0.65
University of California, Davis (UC Davis), United States of America (USA)	5.000000	0.25
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)	1.000000	0.05
University of Pittsburgh (Pitt), United States of America (USA)	0.500000	0.03
University of Pittsburgh Medical Center (UPMC), United States of America (USA)	0.500000	0.03

Interested in Oncology and Carcinogenesis?